Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LUSH (Odorant-binding protein 76a) is a specialized extracellular protein found in the olfactory sensilla of the fruit fly, Drosophila melanogaster [1]. It belongs to the odorant-binding protein (OBP) family, which is characterized by a small, globular structure stabilized by three conserved disulfide bonds [1]. LUSH is primarily known for its essential role in the detection of the male-specific pheromone 11-cis-vaccenyl acetate (cVA), which is crucial for regulating social and mating behaviors [2]. Beyond pheromone transport, LUSH is involved in the fly's chemosensory response to alcohols, such as ethanol and propanol, which influenced its naming [4]. Mechanistically, LUSH acts as a carrier for hydrophobic ligands through the aqueous sensillum lymph, but it also undergoes a specific conformational change upon binding cVA that is required to activate the Or67d/Orco receptor complex [3]. While LUSH is not a human therapeutic target, it serves as a fundamental model for understanding the molecular basis of olfaction and signal transduction in insects [1]. Its unique mechanism of ligand-induced conformational activation makes it a subject of interest for developing highly specific insect repellents or attractants [3]. Consequently, LUSH and its homologs are significant targets in agricultural biotechnology and public health for controlling insect populations and the spread of vector-borne diseases [2].
LUSH functions by binding hydrophobic odorants and pheromones in the sensillum lymph and transporting them to olfactory receptors. Specifically, the binding of 11-cis-vaccenyl acetate (cVA) induces a conformational change in LUSH that directly triggers the activation of the Or67d/Orco receptor complex on sensory neurons [3].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Odorant-binding protein 76a (LUSH) (LUSH).